Hae I. Choi
Ansan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Identification of differentially expressed mRNA/lncRNA modules in acutely regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells.
Journal: PloS one
Published: December 03, 2023
Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells.
Journal: PloS one
Published: November 24, 2021
Targeting of noncoding RNAs encoded by a novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro.
Journal: Scientific reports
Published: September 28, 2021
Identification and Functional Characterization of Two Noncoding RNAs Transcribed from Putative Active Enhancers in Hepatocellular Carcinoma.
Journal: Molecules and cells
Published: July 07, 2021
BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4.
Journal: Scientific reports
Published: October 23, 2020
Forkhead box O1 (FOXO1) controls the migratory response of Toll-like receptor (TLR3)-stimulated human mesenchymal stromal cells.
Journal: The Journal of biological chemistry
Published: April 02, 2019
TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling.
Journal: Oncotarget
Published: September 16, 2016
AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks.
Journal: Oncotarget
Published: March 10, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026